Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Bayer Schering Pharma reports FXIa inhibitors

April 27, 2015

No Comments

FDA grants priority review to idarucizumab BLA

April 24, 2015

No Comments

Bayer patents FXIa inhibitors

April 24, 2015

No Comments

Chugai presents anti-protein-C MAbs

April 17, 2015

No Comments

World Hemophilia Day: Hyperfunctional FIX as a promising tool in hemophilia

April 17, 2015

No Comments

Baxter files for approval of BAX-855 in Japan

April 17, 2015

No Comments

Bayer Schering Pharma patents FXIa inhibitors

April 16, 2015

No Comments

EMA approves compassionate use of OMS-721 in patients with aHUS

April 15, 2015

No Comments

Bayer Schering Pharma presents FXIa inhibitors

April 15, 2015

No Comments

Portola Pharmaceuticals reports topline data from phase III ANNEXA-A trial

April 9, 2015

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Hematologic
RSS

Bayer Schering Pharma reports FXIa inhibitors

FDA grants priority review to idarucizumab BLA

Bayer patents FXIa inhibitors

Chugai presents anti-protein-C MAbs

World Hemophilia Day: Hyperfunctional FIX as a promising tool in hemophilia

Baxter files for approval of BAX-855 in Japan

Bayer Schering Pharma patents FXIa inhibitors

EMA approves compassionate use of OMS-721 in patients with aHUS

Bayer Schering Pharma presents FXIa inhibitors

Portola Pharmaceuticals reports topline data from phase III ANNEXA-A trial

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Proteomics study explores how protein changes influence disease

Abbvie and Simcere enter a $1B T-cell engager deal

Hematologic RSS

Hematologic
RSS